Sifting through countless of stocks in the Diversified Consumer Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Coursera, Inc., GoodRx Holdings or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Coursera, Inc., GoodRx Holdings and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Coursera, Inc., GoodRx Holdings and Inc.

Coursera, Inc. operates an online learning platform that provides education and skills training in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates through Consumer and Enterprise segments. The company offers guided projects, courses, and specializations; online bachelor’s and master’s degrees; postgraduate diplomas; and certificates for entry-level professional, non-entry level professional, university, and MasterTrack programs in the domains of business, computer science, technology, and data science through Coursera.org for Individuals, Coursera Plus, Coursera for Enterprise, Coursera for Business, Coursera for Campus, and Coursera for Government. It offers its products to individuals, businesses, institutions, employers, colleges and universities, organizations, and governments. The company was formerly known as Dkandu, Inc. and changed its name to Coursera, Inc. in April 2012. Coursera, Inc. was incorporated in 2011 and is headquartered in Mountain View, California.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Latest Diversified Consumer Services and Coursera, Inc., GoodRx Holdings, Inc. Stock News

As of September 2, 2026, Coursera, Inc. had a $1.6 billion market capitalization, compared to the Diversified Consumer Services median of $90.5 million. Coursera, Inc.’s stock is NA in 2026, NA in the previous five trading days and down 44.71% in the past year.

Currently, Coursera, Inc. does not have a price-earnings ratio. Coursera, Inc.’s trailing 12-month revenue is $885.4 million with a -15.4% net profit margin. Year-over-year quarterly sales growth most recently was 59.6%. Analysts expect adjusted earnings to reach $0.633 per share for the current fiscal year. Coursera, Inc. does not currently pay a dividend.

Currently, GoodRx Holdings, Inc.’s price-earnings ratio is 73.4. GoodRx Holdings, Inc.’s trailing 12-month revenue is $785.2 million with a 2.1% net profit margin. Year-over-year quarterly sales growth most recently was -1.3%. Analysts expect adjusted earnings to reach $0.304 per share for the current fiscal year. GoodRx Holdings, Inc. does not currently pay a dividend.

How We Compare Coursera, Inc., GoodRx Holdings and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Coursera, Inc., GoodRx Holdings and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Coursera, Inc., GoodRx Holdings and Inc.’s Quality Grades

Company	Ticker	Quality
Coursera, Inc.	COUR	D
GoodRx Holdings, Inc.	GDRX	C

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Coursera, Inc. has a Quality Score of 23, which is Weak. GoodRx Holdings, Inc. has a Quality Score of 53, which is Average.

The Quality Stock Winner: No Clear Winner

Neither Coursera, Inc., GoodRx Holdings or Inc. has a high enough Quality Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Coursera, Inc., GoodRx Holdings or Inc. is the better investment when it comes to quality.

Coursera, Inc., GoodRx Holdings and Inc.’s Momentum Grades

Company	Ticker	Momentum
Coursera, Inc.	COUR	F
GoodRx Holdings, Inc.	GDRX	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Coursera, Inc. has a Momentum Score of 20, which is Very Weak. GoodRx Holdings, Inc. has a Momentum Score of 49, which is Average.

The Momentum Stock Winner: No Clear Winner

Neither Coursera, Inc., GoodRx Holdings or Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Coursera, Inc., GoodRx Holdings or Inc. is the better investment when it comes to momentum.

Coursera, Inc., GoodRx Holdings and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Coursera, Inc.	COUR	C
GoodRx Holdings, Inc.	GDRX	D

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Coursera, Inc. has a Earnings Estimate Score of 56, which is Neutral. GoodRx Holdings, Inc. has a Earnings Estimate Score of 27, which is Negative.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither Coursera, Inc., GoodRx Holdings or Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Coursera, Inc., GoodRx Holdings or Inc. is the better investment when it comes to estimate revisions.

Other Coursera, Inc., GoodRx Holdings and Inc. Grades

In addition to Momentum, Estimate Revisions and Quality, A+ Investor also provides grades for Value and Growth.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Coursera, Inc., GoodRx Holdings and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Coursera, Inc., GoodRx Holdings or Inc. Stock?

Overall, Coursera, Inc. stock has a Momentum Score of 20, Estimate Revisions Score of 56 and Quality Score of 23.

GoodRx Holdings, Inc. stock has a Momentum Score of 49, Estimate Revisions Score of 27 and Quality Score of 53.

Comparing Coursera, Inc., GoodRx Holdings and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.